Piramal Pharma Solutions Announces $80M Expansion Plan for …
WEB1 day ago · Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), has unveiled an $80M ...
Piramal Pharma Solutions Announces $80M Expansion Plan for …
WEB14 hours ago · /PRNewswire/ -- Piramal Pharma Solutions (PPS), ... News provided by. Piramal Pharma Solutions Sep 30, 2024, 10:35 ET. Share this article. Share to X. Share this article.
Piramal Pharma stock in focus on $80 million expansion plan for ...
WEB44 minutes ago · Piramal Pharma shares are in the spotlight on Tuesday after its global contract manufacturing division, Piramal Pharma Solutions (PPS), announced an $80 million investment to expand its sterile injectables facility in Lexington, Kentucky. Piramal's Contract Development and Manufacturing Organization (CDMO) aims to more than double the facility’s capacity by Q1 2027.
Piramal Pharma Solutions investing $80M to expand Lexington ...
WEB10 hours ago · Piramal Pharma Solutions Inc. today announced plans to expand its current Lexington operations with a nearly $80 million investment creating 45 new full-time jobs in the area.
Piramal Pharma Solutions Plans $80M Expansion for Kentucky …
WEB10 hours ago · September 30, 2024. Piramal Pharma Solutions (PPS), a CDMO based in India and part of Piramal Pharma, reports that it plans to invest $80 million to expand its Lexington, KY facility. The site ...
Piramal Pharma Solutions draws $80 mn expansion plan for ... - Mint
WEB12 hours ago · Khushi Malhotra. Published 30 Sep 2024, 09:40 PM IST. The pharmaceuticals firm had previously shared plans to double its turnover to $2 billion by 2030. Piramal Pharma Solutions (PPS), the global ...
Piramal Pharma Solutions Announces $80M Expansion Plan for …
WEB14 hours ago · $80M investment plan will add commercial scale sterile injectables capabilities ; Expansion will significantly increase production capacity and operational efficiency Lexington facility now better capable of supporting increased market demand; MUMBAI, India, Sept. 30, 2024 /CNW/ -- Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and ...
In the News - Piramal Pharma
WEBAug 3, 2023 · Piramal Pharma Limited Announces Consolidated Results for Q4 and FY2023. Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions to Meet Increase in Investigational Drug Demand for Ongoing and Planned Clinical Trials.
Piramal Pharma Solutions Announces $80M Expansion Plan for …
WEB14 hours ago · About Piramal Pharma Solutions. Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to ...
In the News - Piramal Pharma
WEBNov 30, 2023 · ADC Review: Validation of ADC Platform for Protein Concentration and the Drug-Antibody Ratio (DAR) using Variable Pathlength Technology by Conor Barry, Head of Development, Piramal Pharma Solutions. Dec 05, 2023.